Wealth Enhancement Advisory Services, LLC Alkermes Plc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 13,361 shares of ALKS stock, worth $408,980. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,361
Previous 16,107
17.05%
Holding current value
$408,980
Previous $463,000
4.75%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$891 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$557 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$361 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$246 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$211 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.03B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...